0000899243-21-013808.txt : 20210329 0000899243-21-013808.hdr.sgml : 20210329 20210329163510 ACCESSION NUMBER: 0000899243-21-013808 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210325 FILED AS OF DATE: 20210329 DATE AS OF CHANGE: 20210329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rubin Marc CENTRAL INDEX KEY: 0001412377 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 21782130 MAIL ADDRESS: STREET 1: C/O TITAN PHARMACEUTICALS, INC. STREET 2: 400 OYSTER POINT BLVD., STE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC CENTRAL INDEX KEY: 0001133416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043562325 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 BUSINESS PHONE: 678-620-3186 MAIL ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 FORMER COMPANY: FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010612 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-25 0 0001133416 GALECTIN THERAPEUTICS INC GALT 0001412377 Rubin Marc C/O GALECTIN THERAPEUTICS INC. 4960 PEACHTREE INDUSTRIAL BLVD., STE 240 NORCROSS GA 30071 1 0 0 0 Stock option (right to buy) 2.11 2021-03-25 4 A 0 40000 0.00 A 2031-03-25 Common Stock 40000 40000 D Stock option (right to buy) 2.11 2021-03-25 4 A 0 70000 0.00 A 2031-03-25 Common Stock 70000 70000 D The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan. Such options vest 100% on March 31, 2022. Such options vest when (i) the Company has received the interim results of its NAVIGATE clinical trial and (ii) makes a public announcement that it has received the interim results. (1) The reporting person is president and director of Ed Uihlein Family Foundation, a not-for-profit corporation. The reporting person has no pecuniary interest in the shares, however, he shares voting and dispositive power over the shares and, therefore, remains the beneficial owner of the shares solely for the purposes of Section 13(d) of the Securities Exchange Act of 1934. /s/ Jack W. Callicutt, by power of attorney 2021-03-29